Wednesday - April 22, 2026

Bariatric Audience Reports Uptick in Bariatric Surgeries as Providers Expand into New Specialties

Bariatric Audience Bariatric Audience reports a slight rise in bariatric surgeries in 2026 despite growing interest in GLP-1 medications, showing surgery remains vital for long-term weight management. The company also notes many providers are adding specialties like cosmetic and incontinence … Continue reading

CROLabs Launches AI-Powered A/B Testing Platform to Automate Conversion Optimization

AI-powered A/B testing platform dashboard illustrating conversion rate optimization and data-driven experimentation. CROLabs has launched an AI-powered A/B testing tool designed to simplify and accelerate conversion rate optimization. The platform combines automation and data-driven insights to help teams analyze, test, … Continue reading

Multiple Sclerosis Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharma, Sanofi, RemeGen

The Key Multiple Sclerosis Companies in the market include – Biogen, Immune Response BioPharma, ImCyse, Atara Biotherapeutics, Emerald Health Pharmaceuticals, Sanofi, RemeGen, Gossamer Bio, 4D Pharma, HuniLife Biotechnology, Anokion, GSK plc, GeNeuro, Immunic Therapeutics, Sanofi, Hoffman-La-Roche, and others.   DelveInsight’s … Continue reading